NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Mar 07 2022

· Issued by NATCO Pharma Limited

Filed with NSE · · 2 pages · English

Release

Natco Pharma Limited has informed the Exchange about press release dated 07-Mar-2022 titled NATCO Announces Launch of the First Generic Version of Revlimid�� (Lenalidomide capsules), in the U.S. market

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases